(1) If a nursing care facility or a long-term acute care hospital licensed under part 1 of article 3 of title 25 has a quality assessment and assurance committee that includes a pharmacist licensed under this article 280 and is established in accordance with 42 CFR 483.75, the quality assessment and assurance committee may establish a facility list with written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections from the list.
(2) If a nursing care facility or a long-term acute care hospital licensed under part 1 of article 3 of title 25 does not have a quality assessment and assurance committee that includes a pharmacist licensed under this article 280 and is established in accordance with 42 CFR 483.75, the facility may form a committee to establish a facility list with written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections from the list.
Source: L. 2019: Entire title R&RE with relocations, (HB 19-1172), ch. 136, p. 1501, § 1, effective October 1.
Editor's note: This section is similar to former § 12-42.5-501 as it existed prior to 2019.